Tolerability of Budesonide/Formoterol in Patients of Kazakhstan Rural Regions

Clinical and Translational Allergy - United Kingdom
doi 10.1186/2045-7022-5-s2-p21
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Inhaled Combined Budesonide-Formoterol as Needed in Mild AsthmaAs Needed Budesonide-Formoterol Versus Maintenance Budesonide in Mild Asthma

Pediatrics
Child HealthPediatricsPerinatology
2018English

Budesonide-Formoterol Reliever Therapy in Asthma

Thorax
PulmonaryRespiratory Medicine
2006English

Budesonide/Formoterol Combination in COPD: A US Perspective

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2010English

Pharmacokinetics and Tolerability of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate and Glycopyrronium/Formoterol Fumarate Dihydrate Metered Dose Inhalers in Healthy Chinese Adults: A Randomized, Double-Blind, Parallel-Group Study

Clinical Therapeutics
Pharmacology
2019English

Budesonide/Formoterol May Be Used for Adjustable Maintenance Dosing in Asthma

Thorax
PulmonaryRespiratory Medicine
2004English

Therapeutic Equivalence of Budesonide/Formoterol Delivered via Breath-Actuated Inhaler vs pMDI

Respiratory Medicine
PulmonaryRespiratory Medicine
2015English

Long-Term Treatment With Budesonide/Formoterol Attenuates Circulating CRP Levels in Chronic Obstructive Pulmonary Disease Patients of Group D

PLoS ONE
Multidisciplinary
2017English

Real-World Evidence Effect of Budesonide+formoterol Spiromax on Patients With Asthma and Chronic Obstructive Pulmonary Disease in Sweden

European Clinical Respiratory Journal
2019English

Budesonide and Formoterol Reduce Early Innate Anti-Viral Immune Responses in Vitro

PLoS ONE
Multidisciplinary
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy